254 related articles for article (PubMed ID: 22100137)
1. 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.
Ghizzoni M; Wu J; Gao T; Haisma HJ; Dekker FJ; George Zheng Y
Eur J Med Chem; 2012 Jan; 47(1):337-44. PubMed ID: 22100137
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
3. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
4. Small molecule modulators of histone acetyltransferase p300.
Balasubramanyam K; Swaminathan V; Ranganathan A; Kundu TK
J Biol Chem; 2003 May; 278(21):19134-40. PubMed ID: 12624111
[TBL] [Abstract][Full Text] [Related]
5. Small molecule inhibitors of histone acetyltransferase Tip60.
Wu J; Wang J; Li M; Yang Y; Wang B; Zheng YG
Bioorg Chem; 2011 Feb; 39(1):53-8. PubMed ID: 21186043
[TBL] [Abstract][Full Text] [Related]
6. Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
Wapenaar H; van der Wouden PE; Groves MR; Rotili D; Mai A; Dekker FJ
Eur J Med Chem; 2015 Nov; 105():289-96. PubMed ID: 26505788
[TBL] [Abstract][Full Text] [Related]
7. Rational design of substrate-based multivalent inhibitors of the histone acetyltransferase Tip60.
Yang C; Ngo L; Zheng YG
ChemMedChem; 2014 Mar; 9(3):537-41. PubMed ID: 24446345
[TBL] [Abstract][Full Text] [Related]
8. Histone acetyltransferase promotes fluoride toxicity in LS8 cells.
Deng H; Fujiwara N; Cui H; Whitford GM; Bartlett JD; Suzuki M
Chemosphere; 2020 May; 247():125825. PubMed ID: 31927229
[TBL] [Abstract][Full Text] [Related]
9. Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60.
Wu J; Xie N; Wu Z; Zhang Y; Zheng YG
Bioorg Med Chem; 2009 Feb; 17(3):1381-6. PubMed ID: 19114310
[TBL] [Abstract][Full Text] [Related]
10. Histone acetyltransferases: challenges in targeting bi-substrate enzymes.
Wapenaar H; Dekker FJ
Clin Epigenetics; 2016; 8():59. PubMed ID: 27231488
[TBL] [Abstract][Full Text] [Related]
11. Effective Quenchers Are Required to Eliminate the Interference of Substrate: Cofactor Binding in the HAT Scintillation Proximity Assay.
Ngo L; Wu J; Yang C; Zheng YG
Assay Drug Dev Technol; 2015 May; 13(4):210-20. PubMed ID: 26065557
[TBL] [Abstract][Full Text] [Related]
12. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.
Liu X; Wang L; Zhao K; Thompson PR; Hwang Y; Marmorstein R; Cole PA
Nature; 2008 Feb; 451(7180):846-50. PubMed ID: 18273021
[TBL] [Abstract][Full Text] [Related]
13. Characterization of novel inhibitors of histone acetyltransferases.
Eliseeva ED; Valkov V; Jung M; Jung MO
Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
[TBL] [Abstract][Full Text] [Related]
14. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
[TBL] [Abstract][Full Text] [Related]
15. Current development of CBP/p300 inhibitors in the last decade.
He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
[TBL] [Abstract][Full Text] [Related]
16. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
17. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
Bowers EM; Yan G; Mukherjee C; Orry A; Wang L; Holbert MA; Crump NT; Hazzalin CA; Liszczak G; Yuan H; Larocca C; Saldanha SA; Abagyan R; Sun Y; Meyers DJ; Marmorstein R; Mahadevan LC; Alani RM; Cole PA
Chem Biol; 2010 May; 17(5):471-82. PubMed ID: 20534345
[TBL] [Abstract][Full Text] [Related]
18. Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor.
Trievel RC; Li FY; Marmorstein R
Anal Biochem; 2000 Dec; 287(2):319-28. PubMed ID: 11112280
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-CoA biosynthesis drives resistance to histone acetyltransferase inhibition.
Bishop TR; Subramanian C; Bilotta EM; Garnar-Wortzel L; Ramos AR; Zhang Y; Asiaban JN; Ott CJ; Rock CO; Erb MA
Nat Chem Biol; 2023 Oct; 19(10):1215-1222. PubMed ID: 37127754
[TBL] [Abstract][Full Text] [Related]
20. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
